Pamish to supply nucleoside intermediates to Thermo Fisher Scientific

Pamish has signed a contract with Thermo Fisher Scientific to supply nucleoside pharmaceutical intermediates worth 1.347 billion KRW. The contract runs until August 14, 2020.

“파미셀은 미국 Thermo Fisher Scientific사와 의약중간체 뉴클레오시드(Nucleoside) 공급계약을 체결했다고 6일 공시했다.”biz.heraldcorp.com

• 1 source
• biz.heraldcorp.com파미셀, 13억 규모 의약중간체 뉴클레오시드 공급계약 - 헤럴드경제김지현1Mar 6, 2020

Summarized from public sources; check the original articles before acting on it.